Remedy Meds, founded just 18 months ago, is already projecting $450 million in revenue this year and claims to be profitable
Last month (May 2025), Novo Nordisk and Septerna, a San Francisco, California-based bio/pharmaceutical company focused on GCPRs, formed an exclusive global collaboration and license agreement to discover, develop, and commercialize oral small-molecule medicines for treating obesity, Type 2 diabetes, and other cardiometabolic diseases, in a deal worth up to $2.2 billion ($200 million upfront and near-term funding and $2 billion in milestone payments)
Obese teens also have low muscle mass suggesting metabolic syndrome is a muscle thing Could a little bump on a blood vessel be the reason youre insulin resistant
10.1016/S0031-9422(00)89302-4 23 EdeoguC
The blue nevus is a slightly elevated, round, regular nevus, usually less than 0.5 cm, and contains large amounts of pigment located in the dermis ( Figs
Loren Pickart isolated the tripeptide glycyl-L-histidyl-L-lysine (GHK) from human plasma